Ta
Tabuk Pharma
Tabuk SAFounded 19941,500 employees
Private CappharmaPrivateOncology
Platform: Saudi Generic
Market Cap
N/A
All Drugs
3
Clinical Trials
7
Failed / Terminated
1
FDA Approved
0
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| TAB-3211 | TAB-3211 | Phase 3 | 4 | APOC3 | PAHBCC | ||
| TAB-303 | TAB-303 | Phase 3 | 2 | SHP2 | GBM | ||
| TAB-6074 | TAB-6074 | Preclinical | 1 | KRASG12C | PAHNMOSD |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (7)